Endocannabinoid System Research: First-Episode Psychosis
First-episode psychosis predictors include substance use and aggressive behavior, which are linked to criminal legal involvement. Understanding these predictors helps clinicians implement early interventions. The endocannabinoid system research supports…
Clinical Research on Endocannabinoid System and Psychosis
Endocannabinoid system psychosis research provides critical clinical evidence for understanding first episode psychosis. This research highlights correlations between symptom severity and substance use. Early intervention informed by this research may…
`Cannabis-Induced Psychosis and Psychotic Disorders: Key Evidence`
Clinical Takeaway A significant proportion of patients diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder over time. Clinicians should treat cannabis-induced psychosis as a serious warning sign that…
Endocannabinoid System Clinical Research: REAL 2.0 Findings
The REAL 2.0 study highlights endocannabinoid system adolescent mental health factors influencing adult outcomes. Early body image and disordered eating patterns are key indicators. This research supports early screening for mental health and substance…